Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase-Producing Enterobacterales During a Regional Outbreak
- PMID: 32042848
- PMCID: PMC7003035
- DOI: 10.1093/ofid/ofaa011
Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase-Producing Enterobacterales During a Regional Outbreak
Abstract
Limited data about New Delhi metallo-β-lactamase (NDM) bacteremia are available. Blood isolates from 40 patients with NDM bacteremia were studied for antibiotic susceptibility and whole-genomic sequencing. NDM bacteremia has high 30-day mortality. In most cases, aztreonam-avibactam is active in vitro. Ceftazidime-avibactam plus aztreonam may represent a feasible therapeutic option.
Keywords: New Delhi metallo-β-lactamases; bacteremia; carbapenem-resistant.
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
References
-
- European Centre for Disease Control and Prevention. Regional outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacteriaceae, Italy, 2018–2019 June 2019. Available at: https://ecdc.europa.eu/sites/portal/files/documents/04-Jun-2019-RRA-Carb.... Accessed 10 December 2019.
-
- Falcone M, Russo A, Iacovelli A, et al. . Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Clin Microbiol Infect 2016; 22:444–50. - PubMed
-
- Antonelli A, Arena F, Giani T, et al. . Performance of the BD MAX™ instrument with Check-Direct CPE real-time PCR for the detection of carbapenemase genes from rectal swabs, in a setting with endemic dissemination of carbapenemase-producing Enterobacteriaceae. Diagn Microbiol Infect Dis 2016; 86:30–4. - PubMed
-
- International Organization for Standardization, Clinical laboratory testing and in vitro diagnostic test systems. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices—part 1: reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases ISO 20776-1:2019. Available at: https://www.iso.org/standard/70464.html. Accessed on 18 January 2020.